MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to […]
- Home
- con
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok